DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Tokyo Big Sight

2024 年 10 月 27 日 9:30 上午 - 2024 年 10 月 29 日 7:15 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

The 21st DIA Japan Annual Meeting 2024

Toward a Well-Being Future in which Each and Every One of Us Has ‘Ikigai’

Student Session : The Safety Management of Medicines in the Post-Marketing Phase

Session Chair(s)

Mai  Hishinuma

Mai Hishinuma

Keio University, Faculty of Pharmacy, Japan

Mana  Inatome

Mana Inatome

Student, Pharmacokinetics

Showa University, Japan

Rika  Mihara

Rika Mihara

Keio University, Faculty of Pharmacy, Japan

Eiki  Uchijima

Eiki Uchijima

Pharmacy

Nihon University, Japan

Speaker(s)

Natsuko  Kitagawa

Natsuko Kitagawa

Eli Lilly Japan K.K., Japan

Research Scientist, Surveillance. Global Patient Safety Japan

Motoki  Arakawa, PhD

Motoki Arakawa, PhD

Nihon University , Japan

Junior Associate Professor, School of Pharmacy

Katsuhiko  Ichimaru

Katsuhiko Ichimaru

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Review Director, Office of New Drug IV

Jun  Yamakami, PhD

Jun Yamakami, PhD

A2 Healthcare Corporation, Japan

Senior Regulatory Expert, Regulatory Affairs Department Regulatory Consulting

Taigi  Yamazaki, PhD, MPharm

Taigi Yamazaki, PhD, MPharm

Showa University, Japan

Clinical Research Institute for Clinical Pharmacology and Therapeutics

Yoshika  Shinoda

Yoshika Shinoda

Novartis Pharma K.K., Japan

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。